Symbiotec Pharmalab Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE
₹1,598.60
-6.20-0.39% (1D)
As on 20 Nov 2026 at 15:59
As of 20 Nov 2026 at 15:59, Symbiotec Pharmalab Ltd is trading at ₹1,598.60. The 52-week range stands at ₹933.80–₹1,664.90, with a market cap of ₹10.27 thousand crore. At a P/E of 59.63 and a dividend yield of 0.00%, it is a mid-cap stock in the Pharmaceuticals sector.

SYMBIOTEC Price Chart

Market Cap
₹10.27K Cr
PE Ratio
59.63
ROCE
15.77%

Symbiotec Pharmalab Ltd Performance

Symbiotec Pharmalab Ltd Fundamentals

Know More
Market Cap₹10.27K Cr
ROE11.52%
P/E Ratio (TTM)59.63
EPS (TTM)₹26.81
P/B Ratio6.87
Dividend Yield0.00%
Industry P/E91.72
Book Value₹232.71
Debt to Equity0.13
Face Value₹2

Symbiotec Pharmalab Ltd Shareholding Pattern

Know More
Promoter33.3%
Foreign Institutions3.8%
Mutual Funds12.2%
Domestic Institutions21%
Public29.8%

Symbiotec Pharmalab Ltd Financial Statements

Know More
No data for this view.

Symbiotec Pharmalab Ltd Peer Comparison

Know More
StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Sun Pharmaceutical Industries Ltd
₹1,885.10
-14.90(-0.78%)
4,52,298.61,583.7 - 2,046.9
Torrent Pharmaceuticals Ltd
₹4,698.80
87.80(+1.90%)
1,78,727.33,672.3 - 5,250.0
Dr Reddys Laboratories Ltd
₹1,390.50
-10.40(-0.74%)
1,16,144.51,101.0 - 1,414.9
Cipla Ltd
₹1,414.95
-3.55(-0.25%)
1,14,312.11,165.7 - 1,539.7
Lupin Ltd
₹2,010.00
11.20(+0.56%)
91,915.91,892.9 - 2,529.5

About Symbiotec Pharmalab

Symbiotec Pharmalab Private Limited was incorporated as a private limited company, dated September 20, 2002, with the Registrar of Companies, Madhya Pradesh and Chhattisgarh. Subsequently, the name of the Company was changed to Symbiotec Pharmalab Limited and a fresh certificate of incorporation dated September 26, 2025, was issued by the Central Processing Centre. Symbiotec is one of the few companies globally and only Indian manufacturer having continuous manufacturing for progesterone API manufacturing. The Company has its flow chemistry capability being utilized for progesterone in a new block in Pithampur facility. It is presently engaged in manufacturing and selling of Active Pharmaceuticals Ingredients (API) and Intermediates. The Company has a global leadership position in corticosteroid and steroidal-hormone active pharmaceutical ingredients. With over 30 years of industry experience, it has evolved from a lab-scale steroidal-hormone API manufacturer in year 1995 into an industrial-scale, backward-integrated platform with approvals from the United States Food and Drug Administration (USFDA), European Union Good Manufacturing Practices (EU-GMP), Ministry of Food and Drug Safety, Korea and other global organisations. The Company started production of APIs at the Rau Facility in year 2004 and later commenced the same including hormone synthesis at the Pithampur Facility in 2010. In 2012, it commissioned a 5 KL biotech plant at Pithampur and a 35 kilolitres (KL) fermentation project at the Pithampur Facility. The Company had two operational industrial-scale API manufacturing facilities with a maximum chemical synthesis capacity of 584.67 metric tons and fermentation capacity of 300 kilolitres. It has commissioned two additional manufacturing facilities, leading to an aggregate maximum chemical synthesis capacity of 584.67 MT, maximum fermentation capacity of 700 KL, and complex injectables capacity of 20 million vials per annum. The Company later expanded a sterile plant at the Rau Facility in 2022-23. It has commissioned a complex injectables facility at the Mhow and further installed a 400 KL at the Ujjain Plant in FY 2025. Company has filed a Draft Red Herring Prospectus with SEBI and is planning to raise funds through IPO aggregating to Rs 2180 crores, consisting a fresh offer of Rs 150 crore and the offer for sale of Rs 2030 crores having the face value of Rs 2 each.

Parent Organisation—
Founded2002
Managing DirectorANIL KUMAR SATWANI
NSE SymbolSYMBIOTEC

Symbiotec Pharmalab Ltd Resistance and Support levels

R31,671.07R21,648.11R11,633.92S11,588.01S21,573.82S31,550.871,598.60

Symbiotec Pharmalab Ltd Technicals

Current Price
₹1,598.60 ₹6.20 (-0.39%)
Bearish
1
Bullish
11
  • 20 Day9.9%
  • 50 Day25.9%
  • 100 Day29.7%
  • 200 Day29.7%

Symbiotec Pharmalab Ltd Latest News

View More
12 SEPT 2026 | Saturday
Symbiotec Pharmalab shares were re-pledged to Beacon Trusteeship Limited for a debenture

2026

Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial

Frequently asked questions

The share price of Symbiotec Pharmalab Ltd is ₹1,598.60 as of 20 Nov 2026 at 15:59.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now